Production of insulin and enzymes is to be based on renewable energy from Denmark’s largest offshore wind farm, Kriegers Flak in the Baltic Sea.
Global healthcare company Novo Nordisk, bio innovator Novozymes and the energy company Vattenfall have signed a long-term deal. Novo Nordisk and Novozymes will source their power consumption from Vattenfall and its offshore wind farm Kriegers Flak, which is being developed in the Baltic Sea. The deal will cover approximately a fifth of the wind farm’s production. Kriegers Flak is scheduled to be in full operation by the end of 2021 and will have a production capacity of just over 600MW. The deal enters into force from January 1 2020. Between then and 2021 the power will be sourced from other Vattenfall wind farms in Denmark.
